CTRB1 Antibodies

Santa Cruz Biotechnology offers a broad range of CTRB1 monoclonal antibodies for investigating CTRB1 protein function. CTRB1 monoclonal antibodies are validated for multiple applications, including western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). CTRB1, or chymotrypsinogen B1, is a serine protease that plays a crucial role in the digestive process by breaking down proteins in the small intestine. Beyond digestion, CTRB1 participates in inflammation and immune response mechanisms. Research has shown that CTRB1 activity significantly impacts pancreatic function and related disorders. Scientists studying CTRB1 can utilize specific conjugates including horseradish peroxidase (HRP), phycoerythrin (PE), and fluorescein isothiocyanate (FITC) for enhanced detection and visualization. Current research continues to uncover new functions and regulatory mechanisms of CTRB1 in both normal physiology and disease states. Understanding CTRB1's molecular interactions provides valuable insights into potential therapeutic targets for pancreatic disorders. Santa Cruz Biotechnology monoclonal antibodies support researchers worldwide in advancing scientific knowledge of CTRB1's biological significance.